News

Candesic provided commercial due diligence to IVI RMA Global

31 Jul 25

IVI RMA Global has officially acquired ART Fertility Clinics in a landmark deal valued between USD 400–450 million. This acquisition strengthens IVI RMA’s position as the world’s leading reproductive medicine group and expands its presence in key growth markets across the Middle East and ...

Exploring the future of psychedelic treatments in neuroplasticity

17 Jul 25

Candesic had the pleasure of hosting a business dinner at Clearwater Hudson in New York City, led by Aldous Mitchell (Partner) and Blake Edwards (Engagement Manager). The evening brought together a diverse and insightful group of venture capitalists, anaesthesiologists, psychiatrists, and ...

Dr Leonid Shapiro gives expert insights to HBI on the Government’s 10-year plan for the NHS

11 Jul 25

With a strong focus on community care, digital transformation, and prevention the Government’s ambitious 10-Year Plan for the NHS could mark a turning point. Will it?Private sector involvement is on the table — not least in diagnostics, digital infrastructure, and community-based delivery. ...

Candesic’s win at the HealthInvestor Awards

8 Jul 25

We love this photo on the HealthInvestor website of Senior Partner, Marc Kitten and Senior Engagement Manager, Chris Cassar celebrating Candesic’s win at the HealthInvestor Awards alongside presenters Katherine Ryan and Sarah Hyman.This was taken at the ceremony where Candesic was ...

Profits being made by private investors in French healthcare are under fire

8 Jul 25

Following Candesic’s earlier dive into the National Health Insurance Fund (CNAM) proposals, Candesic Senior Partner Marc Kitten spoke to Healthcare Business International about the challenges – and opportunities – this presents going forward.CNAM is looking to tackle a projected €41bn ...

Interesting news from the Health Service Journal (HSJ) ahead of the unveiling of the 10-Year-Health Plan

8 Jul 25

According to the UK-based healthcare news and analysis service, The National Institute for Health and Care Excellence (NICE) is set to “withdraw its backing for a large number of drugs and other intervention” on the basis they now offer “poor value for money”.It adds that a “single ...

Market developments in the press

3 Jul 25

The Candesic team is always happy to share its thoughts on market developments in the press.Dentistry expert Dr Marco Mazevet appears in Healthcare Business International talking about how to tackle UK dental price erosion, tariff levels, and dentists leaving the NHS as patients are gradually ...

Excessive profits in French healthcare? Inside CNAM’s push to regulate private returns

26 Jun 25

The struggling French healthcare sector could be on the brink of profound change with proposals for a new profitability watchdog, and some of the country’s largest for-profit groups in the spotlight following the publication of a new report this week.Private finance profit levels in French ...

Xxplore Women’s Health event

24 Jun 25

Woman’s health is often overlooked when it comes to both research and clinical practice. At the recent XXplore Women’s Health event with NG Bio at The Tallow Chandlers Company, Teresa Pla Prats, Associate at Candesic heard some disappointing facts and figures, including:- It can take up to ...

Dr Leonid Shapiro and Dr Nicolas Correa explore the growing strategic role of radiopharmaceuticals in oncology care

18 Jun 25

As radiopharmaceuticals shift from niche innovation to a strategic pillar of oncology care, Dr Leonid Shapiro, Managing Partner, and Dr Nicolas Correa de Calixto, Engagement Manager at Candesic, explore what’s driving global investor and pharma interest in the June edition of LaingBuisson’s ...